References
- Aoyama T., Korzekwa K., Matsunaga T., Nagata K., Gillette J., Gelboin H. V., Gonzalez F. J. cDNA-directed expression of rat P450s IIAI and IIA2; catalytic activities toward steroids and xenobiotics and comparison with the enzymes purified from liver. Drug Metabolism and Disposition 1990; 18: 378–382
- Brooks J. R., Baptista E. M., Berman C., Ham E. A., Hichens M., Johnston D. B. R., Primka R. L., Rasmusson G. H., Reynolds G. F., Schmitt S. M., Arth G. E. Response of the rat vental prostate to a new and novel 5α-reductase inhibitor. Endocrinology 1981; 109: 830–836
- Carlin J. R., Christofalo P., Arison B. H., Berman C., Brooks J. R., Rasmusson G. H., Rosegay A., Stoner E., VandenHeuvel W. J. A. Metabolism and disposition of MK-906 in laboratory animals and man. Pharmacologist 1987; 29: 149
- Carlin J. R., Christofalo P., Arison B. H., VandenHeuvel W. J. A., Miller R. R., Ellsworth R. L., Chiu S. H. L. The disposition and pharmacokinetics of finasteride in the dogs. Fourth North American ISSX Meeting 1992a; 2: 197, (Abs)
- Carlin J. R., Hoglund P., Eriksson L. O., Christofalo P., Gregoire S. L., Taylor A. M., Andersson K. E. Disposition and pharmacokinetics of [14C]finateride after oral administration in human. Drug Metabolism and Disposition 1992b; 20: 148–155
- Cohen S. M., Taber K. H., Malatesta P. F., Shpungin J., Berman C., Carlin J. R., Werrmann J. G., Prahalada S., Bryan R. N., Cordes E. H. Magnetic resonance imaging of the efficacy of specific inhibition of 5α-reductase in canine spontaneous benign prostatic hyperplasia. Magnetic Resonance in Medicine 1991; 21: 55–70
- Funae Y., Imaoka S. Cytochrome P450 in rodents. Cytochrome P450, J. B. Schenkman, H. Greim. Springer, Berlin 1993; 221–238
- Imaoka S., Fujita S., Funae Y. Age-dependent expression of cytochrome P-450s in rat liver. Biochimica et Biophysica Acta 1991; 1097: 187–192
- Ishii Y., Makoyama H., Ohtawa M. In vitro biotransformation of finasteride in rat hepatic microsomes: Isolation and characterization of metabolites. Drug Metabolism and Disposition 1994; 22: 79–84
- Kato R., Yamazoe Y. Hormonal regulation of cytochrome P450 in rat liver. Cytochrome P450, J. B. Schenkman, H. Greim. Springer, Berlin 1993; 447–459
- Liang T., Heiss C. E., Cheung A. H., Reynolds G. F., Rasmusson G. H. 4-Azasteroidal 5α-reductase inhibitors without affinity for the androgen receptor. Journal of Biological Chemistry 1984; 259: 734–739
- Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
- Nagata K., Gonzalez F. J., Yamazoe Y., Kato R. Purification and characterization of four catalytically active testosterone 6β-hydroxylase P-450s from rat liver microsomes: comparison of a novel form with three structurally and functionally related forms. Journal of Biochemistry (Tokyo) 1990; 107: 718–725
- Nagata K., Matsunaga T., Gillette J., Gelboin H. V., Gonzalez F. J. Rat testosterone 7α-hydroxylase: isolation, sequence, and expression of cDNA and its developmental regulation and induction by 3-methylcholanthrene. Journal of Biological Chemistry 1987; 262: 2787–2793
- Rasmusson G. H., Liang T., Brooks J. R. A new class of 5α-reductase inhibitors. Gene Regulation by Steroid Hormones II, A. K. Roy, J. H. Clark. Springer, New York 1983; 311–334
- Stoner E., Bracken R. B., Stein E., Franke K., Geller J., Pratt C., Imperato-McGinley J., Vaughan F. D., Jr, Orlic S., McConell J. D., Wilson J., Hill L., Roy J. B., Einfeldt S., Tenover L., Zeitner M., Pappas F., Gregg H. The clinical effects of a 5α-reductase inhibitor, finasteride, on benign prostatic hyperplasia. Journal of Urology 1992; 147: 1298–1302
- Waxman D. J. Interactions of hepatic cytochromes P-450 with steroid hormones. Biochemical Pharmacology 1988; 37: 71–84